Financials
- Market Capitalization 12.63 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
146.72
市销率
3.28
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 706 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.78 USD | +0.25% | -6.47% | -5.48% | +34.70% | 15.01 B USD | ||
| 753 | EXEL Exelixis, Inc. - Common Stock | 55.37 USD | +1.34% | -0.27% | +5.21% | +41.83% | 13.72 B USD | ||
| 797 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 538.99 USD | -0.19% | +3.86% | +16.63% | +27.24% | 12.45 B USD | ||
| 806 | CORT Corcept Therapeutics Incorporated - Common Stock | 114.48 USD | +1.00% | -7.78% | +0.28% | +56.03% | 12.38 B USD |